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A Defect in the Kv Channel-Interacting Protein 2
(KChIP2) Gene Leads to a Complete Loss of Ito and
Confers Susceptibility to Ventricular Tachycardia
cates that mutations in cardiac ion channels themselves
can be a primary mechanism for ventricular arrhythmias
(for a review, see Keating and Sanguinetti, 2001). How-
ever, it is clear that a defect in these ion channels alone
is not sufficient to induce arrhythmias. Extensive pheno-
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for the disease phenotype and indicates that the under-2 Department of Physiology & Biophysics
lying cause for the onset of lethal arrhythmias is multifac-Faculty of Medicine
torial. Since the inheritable long QT syndrome accountsUniversity of Calgary
for only 1%–2% of lethal ventricular arrhythmias seenAlberta T2N 4N1
clinically, other pathways must exist to confer suscepti-Canada
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Most cases of lethal arrhythmias are associated withUniversity of Iowa
acquired forms of heart diseases, including heart failureIowa City, Iowa 52242
and hypertrophy. Dysregulation of a panel of ion trans-
porters and channel genes and their associated currents
is a common feature in heart failure and hypertrophySummary
(Chien, 1999), accounting for the high risk of lethal ar-
rhythmias associated with these diseases. Among allKChIP2, a gene encoding three auxiliary subunits of
the changes in electrophysiological remodeling, theKv4.2 and Kv4.3, is preferentially expressed in the adult
challenge has been to identify which alterations are es-heart, and its expression is downregulated in cardiac
sential for conferring a susceptibility to lethal cardiachypertrophy. Mice deficient for KChIP2 exhibit normal
arrhythmias. The identification of specific pathways thatcardiac structure and function but display a prolonged
regulate the expression of critical currents might leadelevation in the ST segment on the electrocardiogram.
to new therapeutic strategies for preventing the onsetThe KChIP2/ mice are highly susceptible to the in-
of lethal arrhythmias. In this regard, recent studies haveduction of cardiac arrhythmias. Single-cell analysis
shown that the dysregulation of ion channel gene ex-revealed a substrate for arrhythmogenesis, including
pression during conduction system development cana complete absence of transient outward potassium
lead to cardiac sudden death (Chien, 2000; Nguyen-current, Ito, and a marked increase in action potential
Tran et al., 2000). Previous studies have also shown thatduration. These studies demonstrate that a defect in
the most consistent change in sarcolemma ionic currentKChIP2 is sufficient to confer a marked genetic sus-
in both human and experimental models of heart failureceptibility to arrhythmias, establishing a novel genetic
is a marked downregulation of the calcium-independentpathway for ventricular tachycardia via a loss of the
transient outward potassium current, Ito (for a review,transmural gradient of Ito. see Tomaselli and Marban, 1999). Ito is responsible for
the early phase of repolarization of the cardiac action
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potential, and it is expressed in a highly conserved epi-
cardial-to-endocardial gradient across the ventricular
Cardiac arrhythmias are a leading cause of morbidity free wall (Na¨bauer et al., 1996). A reduction in Ito is notand mortality in developed nations. Each year, more only a prominent but also an early feature of heart failure
than 300,000 individuals in the United States die sud- (Ka¨a¨b et al., 1996). However, despite this association,
denly, and most of these sudden deaths occur as the it is not clear whether a downregulation of Ito is critical
result of a rapid onset of lethal ventricular arrhythmias to the increased susceptibility to lethal arrhythmias that
(Zipes and Wellens, 1998). The identification of muta- can be seen in heart failure patients.
tions in various potassium and sodium channels (in- Ito is generated mainly by two voltage-gated potas-
cluding KVLQT1, HERG, SCN5A, minK, and MiRP1) in sium (Kv) channels, Kv4.2 and Kv4.3, in mammalian
individuals with familial forms of long QT syndrome indi- hearts (Barry et al., 1995; Dixon et al., 1996). The Kv gene
family consists of nine subfamilies, Kv1–Kv9. Altogether,
4 Correspondence: kchien@ucsd.edu they encode more than 30 mammalian Kv  subunits,
5 These authors contributed equally to this work. which can tetramerize with members of the same sub-
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Two classes of cytoplasmic auxiliary proteins for Kv, respectively. A sequence search showed that, despite
the alternative splicing, all three KChIP2 isoforms con-the Kv  subunits and KChAP, have previously been
identified, both of which can regulate the functional ex- tain four copies of the EF-hand domain, a calcium bind-
ing motif, in their carboxyl termini (Figures 1A and 1B),pression of specific potassium channels. (Rettig et al.,
1994; Shi et al., 1996; Wible et al., 1998). The identifica- and all the isoforms were confirmed to bind Ca2 (data
not shown).tion and characterization of auxiliary proteins for Kv
channels is a new and rapidly expanding area of re-
search. Recently, a novel class of auxiliary proteins for KChIP2 Is Preferentially Expressed in Adult
Kv4  subunits, the Kv channel-interacting protein Myocardium, Whose Expression Is Downregulated
(KChIP) family, has been cloned from the brain. Mem- in Cardiac Hypertrophy
bers of this family, including KChIP1, KChIP2, and Northern blot analysis showed that the expression of
KChIP3, can interact with both Kv4.2 and Kv4.3 and KChIP2 was highly restricted to the heart and was pres-
regulate the function of these channels when coex- ent, to a much lesser extent, in the brain, yielding an
pressed in heterologous cells (An et al., 2000). However, mRNA of approximately 2.4 kilo bases (kb) (Figure 2A).
despite these in vitro findings, the in vivo function of To determine whether there was a dominant KChIP2
KChIPs remains unclear. isoform in the heart, a quantitative reverse transcriptase-
In the present study, we report the independent clon- polymerase chain reaction (RT-PCR) was performed.
ing of the KChIP2 gene as well as the in vivo functional The analysis of the relative cardiac expression of the
study of this gene in mice null for KChIP2. The KChIP2/ three KChIP2 isoforms showed that mRNAs corre-
mice showed no signs of cardiac dysmorphogenesis, sponding to KChIP2a, KChIP2b, and KChIP2c were
contractile dysfunction, hypertrophy, or heart failure but present in the adult mouse heart at a relative ratio of
were highly susceptible to the induction of ventricular approximately 2:2:1 (Figure 2B). This ratio was very close
tachycardia. Single-cell analysis demonstrated a com- to that obtained during cDNA library screening, in which,
plete, selective loss of Ito in the KChIP2/ myocytes and out of six independent cDNA clones isolated from an
revealed an essential role of KChIP2 in controlling the adult heart library, the number of clones corresponding
Kv4.2-mediated current, Ito, in vivo. In addition, there was to KChIP2a, KChIP2b, and KChIP2c was 3, 2, and 1,
an approximate 50% reduction of Ito in the heterozygous respectively. These data indicated that there was no
deficient mice, indicating that KChIP2 can quantitatively specific KChIP2 isoform dominating the cardiac expres-
regulate Ito. As a result of the loss of Ito, the action poten- sion. KChIP2a and KChIP2b were present in the adult
tial was prolonged and the normal transmural gradient heart at about an equal level, whereas KChIP2c was the
of Ito expression in the ventricle was abolished. The re- least abundant form.
sulting increase in dispersion of repolarization can pro- While KChIP2 was abundantly expressed in adult
vide a substrate for cardiac arrhythmias. Taken together, hearts, its expression was barely detectable in pooled
our study shows that a defect in KChIP2 is sufficient to hearts from mouse embryos of days 13–15 postcoitus
confer a marked genetic susceptibility to arrhythmias (Figure 2C). This developmental upregulation of KChIP2
and indicates that KChIP2 may represent a new class expression in the adult heart indicated that KChIP2 was
of genetic modifiers for cardiac arrhythmias. Further- likely to play a physiological, rather than a develop-
more, it demonstrates that the loss of the physiological mental, role in the heart. To further determine whether
transmural gradient of Ito is critical to conferring suscep- KChIP2 was expressed in the myocardium of the heart,
tibility to arrhythmias. an in situ hybridization analysis was subsequently per-
formed. While the cardiac expression of KChIP2 was
barely detectable at embryonic day 15 (data not shown),Results
its expression was clearly visible in cardiac myocytes
at embryonic day 17 (Figures 2D and 2E). In addition toThe KChIP2 Gene Can Generate Three Protein
Isoforms by Alternative Splicing myocardium, KChIP2 expression was localized to cer-
tain specific regions in the nervous tissue, including theWe independently cloned KChIP2 out of a yeast two-
hybrid heart library by using the cardiac-restricted an- olfactory lobe, part of the medulla oblongata, and certain
types of cells in the dorsal root ganglion of the spinalkyrin repeat protein as the bait. To characterize the
KChIP2 gene, both its cDNA and genomic DNA were cord (Figures 2F and 2G).
To further determine whether an alteration of KChIP2isolated. Analysis of the isolated cDNA clones versus
the genomic structure revealed that the KChIP2 gene expression could be involved in heart disease, we exam-
ined KChIP2 expression in a mouse model of left ventric-contained ten exons, in which exons 2 and 3 were op-
tional. A single open reading frame was identified with ular hypertrophy induced by pressure overload using
transverse aortic constriction (TAC). These experimentsthe translational start and stop codons located in exons
1 and 10, respectively (Figure 1A). By alternative splicing showed that KChIP2 expression was significantly re-
duced four days after the TAC procedure (Figure 2H).of exons 2 and 3, the KChIP2 gene may generate three
protein isoforms, KChIP2a, KChIP2b, and KChIP2c, in This decrease in KChIP2 expression was associated
with the development of cardiac hypertrophy, indicatedwhich KChIP2a contains all ten exons, KChIP2b lacks
exon 3, and KChIP2c lacks exons 2 and 3 (Gen- by the induction of the expression of the atrial naturetic
factor (ANF) gene (Figure 2H), a marker for heart hyper-Bank accession numbers AF439339, AF439340, and
AF439341). The expected sizes of KChIP2a, KChIP2b, trophy, as well as a significant increase in the left ventri-
cle/body weight ratio (data not shown).and KChIP2c are 270, 252, and 220 amino acids (aa),
KChIP2 and Ventricular Tachycardia
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Figure 1. The KChIP2 Gene and Its Three Isoforms
(A) Schematic drawings of the KChIP2 gene and its three isoforms generated by alternative splicing. Exons, introns, and alternative splicing
events are denoted as square boxes, solid horizontal lines, and dashed lines, respectively. Exon 2, exon 3, and the four EF-hand domains
are represented in yellow, red, and blue, respectively. The translational start codon (ATG) and the stop codon (TAG) are indicated above their
respective positions, and the sizes of the three isoforms are shown on the right.
(B) Sequence of the mouse KChIP2. The nucleotide and the decoded amino acid sequences in each exon are shown, with the number for
the amino acid sequence indicated on the right. The translational start codon, the stop codon, and the four EF-hand domains are underlined.
Generation of KChIP2/ Mice techniques revealed no abnormalities in the heart of the
KChIP2/ mice (data not shown).The preferential expression of KChIP2 in adult myocar-
dium as well as its downregulation in cardiac hypertro-
phy suggest that KChIP2 may have a functional role in
The KChIP2/ Mice Are Highly Susceptible
the adult heart. To study its function in vivo, we gener- to the Induction of Arrhythmias
ated mice null for KChIP2. A gene-targeting construct During the generation of these KChIP2/ mice, it was
containing a deletion of exons 4–9 in the KChIP2 gene reported that KChIP2, corresponding to one of our iso-
was electroporated into embryonic stem (ES) cells (Fig- forms, KChIP2b, could modulate the function of Kv4.2
ure 3A). A total of 1036 ES cells were screened by South- when coexpressed in heterologous expression systems
ern blot analysis, and five clones were identified to be (An et al., 2000). Accordingly, implantable radiotelemetry
positive. Two of the targeted ES cell clones were used was used to determine whether there were any defects
to establish mouse lines carrying the KChIP2 mutation. in the cardiac electrophysiological properties of the
Mice homozygous for the targeted KChIP2 allele were KChIP2/ mice. Continuous electrocardiographical
confirmed by Southern blot analyses with both a 5 and monitoring for over two weeks in conscious mice
a 3 probes (Figure 3B). A Northern blot analysis subse- showed that the KChIP2/ mice had no baseline, spon-
quently showed that the deletion of exons 4–9 of the taneous arrhythmias. With an exception of a prolonged
KChIP2 gene completely abolished the expression of duration of elevated ST segment (12.6  2.07 ms, n 
the gene in the homozygous mice; whereas in the het- 4 versus 7.9 1.2 ms, n 4; p 0.05), the ECG pattern
erozygous mice there was an approximate 50% reduc- of the KChIP2/ mice was generally normal, including
tion in KChIP2 expression (Figure 3C). The KChIP2/ a normal QT interval (Figure 3D).
mice were born with an expected Mendelian frequency, Because the change in the ST segment on the ECG
indicating no embryonic lethality. They grew into adult- suggests a defect in cardiac repolarization, we were
hood externally indistinguishable from their wild-type interested in determining the susceptibility of the
littermates. A detailed examination of cardiac chamber KChIP2/ mice to cardiac arrhythmias. The in vivo sus-
volume size, wall thickness, contractility, and tissue sec- ceptibility to arrhythmias can be gauged in humans and
experimental animals by programmed stimulation. Ations using both echocardiographical and histological
Cell
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Figure 2. Expression Patterns of the KChIP2 Gene
(A) Multiple-tissue Northern blot analysis demonstrating that KChIP2 is preferentially expressed in the mouse heart.
(B) RT-PCR analysis showing the relative expression of the three KChIP2 isoforms in the adult mouse heart. Control indicates a duplicate
reaction with no reverse transcriptase added.
(C) Northern blot analysis showing KChIP2 expression in pooled embryonic hearts (embryonic days 13–15) versus adult hearts.
(D) In situ hybridization analysis of KChIP2 expression in a mouse embryo of day 17 postcoitus.
(E) Magnified view of the heart from (D).
(F) Magnified view of the brain from a 15-day-old mouse embryo.
(G) Magnified view of the spinal cord from a 17-day-old mouse embryo.
(H) KChIP2 expression is decreased in cardiac hypertrophy induced by pressure overload. Total RNA was isolated from the left ventricle of
mice that underwent various lengths of time of the TAC procedure (TAC) or sham-operation (Sham) as indicated at the top.
standard protocol of programmed stimulation was used fested as polymorphic ventricular tachycardias, which
were shown on these ECGs as a circulating wave with ato define the susceptibility to arrhythmias in both the
control (n  10) and mutant (n  12) mice (Berul et continually changing configuration. These polymorphic
ventricular tachycardias were either sustained (n  2)al., 1996). While none of the control mice developed
inducible arrhythmias when electrically stimulated (Fig- or nonsustained (n 6), with the longest duration lasting
for 17 s and over 400 beats. Induced atrial arrhythmiasure 4A), 9 out of the 12 KChIP2/ mice developed either
atrial (n  1) or ventricular (n  8) arrhythmia (Figures closely resembled episodes of atrial flutter, sometimes
lasting longer than 2 min (data not shown). All these4B–4D). The induced ventricular arrhythmias were mani-
KChIP2 and Ventricular Tachycardia
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Figure 3. Gene Targeting Strategy, Generation of the KChIP2/ Mice, and ECG Recordings from the KChIP2/ Mice
(A) Diagram of the KChIP2 endogenous locus, the targeting construct, and the targeted KChIP2 locus. Exons are denoted as open boxes
with number indicated below. Restriction enzyme sites are shown with the following abbreviations: K, KpnI; H, HindIII; B, BglII; R, EcoRI; N,
NotI; and X, XhoI.
(B) Southern blot analyses of KpnI-digested genomic DNA from wild-type (/), heterozygous (/), and homozygous (/) KChIP2 mice.
The 5 and 3 probes used to analyze the targeted allele are indicated as black rectangles in (A). When digested with KpnI, the wild-type allele
will produce a 15.2 kb band with both probes, whereas a targeted allele will produce 5.9 kb and a 9.3 kb bands with the 5 and the 3 probes,
respectively, as a result of an introduced KpnI site.
(C) Northern blot analyses of RNA from wild-type (/), heterozygous (/), and homozygous (/) KChIP2 mice.
(D) Representative ECGs of lead II recorded from conscious mice with radiotelemetry. The ECGs from KChIP2/ mice showed a prolonged
elevation in the ST segment (arrow) when compared to the control littermates.
rhythmic disturbances could be induced reproducibly A Complete Loss of the Transient Outward
Potassium Current (Ito) in KChIP2/in the KChIP2/ mice (	10 episodes). To assess the
conduction properties of the sinus node, atrioventricular Ventricular Myocytes
To identify the underlying mechanisms that may medi-node, atria, and ventricles, intracardiac electrophysio-
logical studies were also performed; however, no signifi- ate the observed susceptibility to arrhythmias in the
KChIP2/ mice, cardiac myocytes were isolated fromcant differences were found between the control and
mutant groups (Table 1). right ventricles of both the wild-type and KChIP2/
Cell
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Figure 4. Inducible Ventricular Arrhythmias in the KChIP2/ Mice
(A) Representative ECG tracing from the wild-type mice. Programmed stimulation with rapid ventricular pacing (S1) and extra stimulus failed
to induce either ectopy or ventricular arrhythmia in the control mice. The surface ECG (SECG) tracing is shown in red, and the intracardiac
ECG (IECG) tracing is shown in blue.
(B) Nonsustained polymorphic ventricular tachycardia (VT). The same protocol of programmed stimulation applied to the wild-type mice
induced nonsustained VT with polymorphic QRS complexes in the KChIP2/ (KO) mice.
(C) Torsades de pointes. KO mice with inducible VT exhibited Torsades de pointes-like polymorphic VT on the SECG.
(D) Sustained polymorphic ventricular tachycardia. KO mice developed sustained VT lasting nearly 15 s.
mice. K currents in the isolated cells were recorded large rapidly activating and rapidly inactivating compo-
nent of outward K current. In agreement with this, theusing the conventional whole-cell voltage clamp tech-
nique. The superimposed K current recordings showed outward currents from the mutant cells are very similar
to those from control cells when recorded immediatelythat the outward currents in the control cells have the
expected biphasic time course of decay, consisting of following an inactivating prepulse, which selectively and
strongly reduced the transient outward K current, Itoa rapid initial phase followed by a much slower second
phase (Figure 5A). In contrast, the outward K currents (Figures 5B and 5C). In contrast to the dramatic effect
of the inactivating prepulse on currents from the controlin the mutant cells have only a single, slow phase of
inactivation (Figure 5B). This analysis suggested that cells (Figures 5A and 5C), the same prepulse had very
little effect on the magnitude or the time course of thethe ventricular myocytes from mutant animals lack the
KChIP2 and Ventricular Tachycardia
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Table 1. Summary of Intracardiac Electrophysiological Data
Pacing Parameters SNRT SCL CSNRT APWenk AP2:1 AVERP100 AERP100 VERP100
Wild-type (n  10) Mean 194.4 151.7 42.8 101.8 83.1 73.5 58.5 44.1
SD 16.2 21.3 17.5 12.2 12.5 7.4 9.4 14.5
Knockout (n  12) Mean 211.5 167.1 44.4 92.9 73.7 65.0a 52.1 35.3b
SD 8.3 17.5 16.3 9.8 9.1 11.5 11.3 12.8
All interval values are in milliseconds. Abbreviations are as follows: SNRT, sinus node recovery time; SCL, sinus cycle length; CSNRT, corrected
sinus node recovery time; APWenk, atrial pacing Wenckebach cycle length; AP2:1, atrial pacing 2:1 atrioventricular block cycle length; AVERP,
atrioventricular (and/or His-Purkinje system) effective refractory period; AERP, atrial effective refractory period; and VERP, ventricular effective
refractory period.
a p value  0.06
b p value  0.14
outward currents in the mutant cells (Figures 5B and 5D). Ito was isolated as the ”difference current” which was
sensitive to the inactivating prepulse. As shown, thisSimilar results were also obtained from left ventricular
epicardial myocytes isolated from the control and mu- “difference current” was considerably larger in the con-
trol cells than in the heterozygous cells, although thetant mice (data not shown).
The mean peak current-voltage relations recorded time constant of inactivation was identical. The mean
amplitude of Ito isolated at 30 mV in the heterozygousfrom the control and mutant myocytes in the presence
and absence of the inactivating prepulse are compared myocytes was about 42%, almost half of that in the wild-
type myocytes (10.9  1.4 pA/pF, n  13 versus 25.7 (Figures 5E and 5F). In the control cells, the inactivating
prepulse produced a significant difference in the magni- 2.2 pA/pF, n 16) (Figure 5H). In contrast, there was only
a background level of Ito in the homozygous myocytes.tude of the current for membrane potentials more posi-
tive than 30 mV. At 60 mV, this difference in peak These findings clearly demonstrate a gene dosage effect
of KChIP2 on the expression of Ito and show that thecurrent density (i.e., with and without the prepulse) aver-
aged about 1.8-fold. In contrast, in the mutant cells, the relative level of KChIP2 expression can quantitatively
determine the current density of Ito in cardiac myocytes.inactivating prepulse had very little effect on the peak
current at any membrane potential. Taken together,
these studies revealed that the rapidly activating and A Loss of the Normal Transmural Gradient of Ito
Expression in the Left Ventricle of KChIP2/ Miceinactivating transient outward K current, Ito, is virtually
absent in the cardiac myocytes of the KChIP2/ mice, Previous studies in humans and larger animals have
demonstrated the presence of a conserved epicardial-demonstrating that KChIP2 is essential for the expres-
sion of Ito in the heart. Importantly, the density of the to-endocardial gradient of Ito expression across the ven-
tricular free wall (Na¨bauer et al., 1996; Rosati et al.,inward rectifier K current, Ik1, recorded at membrane
potentials negative to 80 mV, in the mutant cells was 2001). To determine whether such a gradient also exists
in mice, left ventricular epicardial and endocardial myo-not significantly different from that in the control cells,
indicating a selective effect of KChIP2 on Ito. cytes were isolated from both the wild-type and
KChIP2/ mice. In the control group, the mean ampli-
tude of Ito isolated at30 mV in the epicardial myocytesThe Relative Level of KChIP2 Expression Can
Quantitatively Determine the Current Density was approximately twice as high as that in the endocar-
dial myocytes, indicating the presence of a transmuralof Ito in Cardiac Muscle Cells
To determine whether there was any gene dosage effect gradient of Ito expression in the left ventricle of the wild-
type mice (Figure 5I). In contrast, a comparison of theof KChIP2 on the expression of Ito, single-cell recordings
were performed using right ventricular myocytes iso- mean amplitude of Ito between the epicardial and endo-
cardial myocytes of the KChIP2/ mice clearly showedlated from the wild-type and heterozygous mice. The
extremely thin wall of the adult mouse right ventricle that this normal epicardial-to-endocardial transmural
gradient of Ito expression was abolished in the KChIP2/(approximately 1 mm) makes it unlikely that any trans-
mural gradient for the expression of Ito will be present mice.
to confound the quantitative data analysis. Mean peak
current-voltage relations from control and heterozygous KChIP2/ Myocytes Have Prolonged Action
Potentials and Exhibit a Rate-Dependentmyocytes in the presence and absence of the inactivat-
ing prepulse are compared (Figure 5E). In the absence Effect on the Action Potential Duration
Since Ito is responsible for the early repolarization ofof the inactivating prepulse, the peak current density of
the heterozygous cells was smaller at all membrane cardiac action potential, we examined the effect of the
loss of Ito on action potentials. Action potentials re-potentials than in the control cells. An application of the
prepulse reduced the peak current densities in right corded from right ventricular myocytes of the wild-type
and the KChIP2/ mice revealed two differences (Figureventricular myocytes from both groups of mice to a
similar level. These results indicate that Ito is expressed, 6A). First, the action potential in the mutant cells was
longer in duration than that from a control cell. Second,but at a much decreased level, in the heterozygous cells
as compared to the control cells. To examine the relative the action potential duration (APD) in the mutant cells
increased as the stimulation frequency increased fromlevel of Ito in these cells in more detail, a “paired” voltage-
clamp protocol was utilized (Figure 5G). In this study, 1 Hz to 5 Hz, whereas the APD of the control cells
Cell
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Figure 5. Loss of the Transient Outward K
Current, Ito, in KChIP2/ Myocytes
The absence of the transient outward K cur-
rent, Ito, in the KChIP2/ myocytes, the gene
dosage effect of KChIP2 on the expression
of Ito, and the loss of the normal transmural
gradient of Ito expression in the left ventricle
of the KChIP2/ mice. In isolated myocytes,
families of membrane currents were pro-
duced by voltage clamp steps from120 mV
to 60 mV in 10 mV steps from a holding
potential of 80 mV. An “inactivating pre-
pulse” (40 mV for 75 ms), which preceded
each step, was included in some experiments
to selectively inactivate Ito.
(A) Representative K currents from the wild-
type myocytes.
(B) Representative currents from the
KChIP2/ myocytes.
(C) Representative currents from the wild-
type myocytes in the presence of the inacti-
vating prepulse.
(D) Representative currents from the
KChIP2/ myocytes in the presence of the
inactivating prepulse.
(E) Mean peak current density (current/
capacitance) versus membrane potential for
wild-type (n  16) and heterozygous myo-
cytes (n  16). Data points are mean  SEM.
Peak current densities from the wild-type and
heterozygous cells are shown in black and
red, respectively. Black filled and open circles
indicate current densities in the absence and
presence of the inactivating prepulse in wild-
type cells, respectively. Red filled and open
squares indicate current densities in the ab-
sence and presence of the prepulse in the
heterozygous cells, respectively.
(F) Mean peak current density versus mem-
brane potential for KChIP2/ myocytes (n 
16). Data points are mean  SEM. Filled cir-
cles indicate peak current density in the ab-
sence of the inactivating prepulse; open cir-
cles denote peak currents in the presence of
the prepulse.
(G) Isolation of Ito as a “difference current” from wild-type (wt), heterozygous (ht), and homozygous (ko) myocytes using a paired voltage clamp
step protocol. Two depolarizing steps were applied sequentially; one of the steps was preceded by an inactivating prepulse (), and the other
was not (). The difference current was obtained by subtraction. Note that the “raw” (top) and “difference” (bottom) currents are shown in
different scales.
(H) Histograms comparing the mean amplitude ( SEM) of the Ito isolated from wild-type (n  16), heterozygous (n  13), and homozygous
(n  9) myocytes (asterisk, p  0.001 compared with wt).
(I) Histograms comparing the mean amplitude ( SEM) of Ito isolated from left ventricular epicardial (n  9) and endocardial (n  7) myocytes
of the wild-type (wt) mice, as well as left ventricular epicardial (n  3) and endocardial (n  4) myocytes of the homozygous (ko) mice.
Abbreviations are as follows: Epi, epicardial myocytes; Endo, endocardial myocytes. Asterisk, p  0.05, wt, endo compared with wt, epi (one-
way ANOVA on all data sets). The difference in mean Ito amplitude between epi and endo in the KO mice was not significant.
was not altered significantly by changing stimulation cells was significantly greater than unity at both 50%
and 90% repolarization times (p  0.02). Thus, whilefrequency. The mean durations of action potential from
the mutant cells were significantly longer than those APDs from the control cells were independent of the
stimulation frequency, action potentials from the mutantfrom the control cells, measured at 50% and 90% repo-
larization and at stimulation frequencies of 1 and 5 Hz cells were significantly prolonged by an increase in the
stimulation frequency, demonstrating a rate-dependent(p  0.01) (Figure 6B). Thus, a loss of Ito can prolong the
action potential and alter its frequency dependence. effect on APD in the KChIP2/ myocytes.
The significance of the frequency-dependent differ-
ences on the APD in the mutant cells was evaluated by Discussion
using the ratio of APD at a selected stimulation fre-
quency of 5 Hz to 1 Hz for individual cells, and then KChIP2 Is an Essential Regulator of the Transient
Outward Potassium Currentaveraging these ratios (Figure 6C). This analysis showed
that the mean ratio from the control cells was not signifi- Previous studies have identified three distinct groups
of cytoplasmic protein, including KChIPs, Kv  subunits,cantly different from unity at either 50% or 90% repolar-
ization times. In contrast, the mean ratio from the mutant and KchAP, that can interact with specific Kv  subunits
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By generating the KChIP2/ mice, we have shown
that KChIP2 is not only involved in the regulation of Ito
but also is essential to the expression of Ito in the heart. In
the absence of KChIP2, there is a complete and selective
loss of Ito. Furthermore, the analysis of the gene dosage
effect of KChIP2 on Ito expression reveals that the rela-
tive level of KChIP2 expression can quantitatively deter-
mine the current density of Ito in cardiac myocytes. This
absolute requirement of KChIP2 for Ito expression in vivo
is quite unexpected considering that KChIP2s, like Kv-
subunits, are only auxiliary subunits of Kv channels. It
has been shown that Kv1.1, an auxiliary  subunit for
the Kv1.1, Kv1.2, and Kv1.4 channels, can confer fast
inactivation to these A type K channels in vitro. In con-
trast to the essential and quantitative role of KChIP2 for
Ito expression, previous studies of Kv1.1-deficient mice
have shown that a loss of Kv1.1 may cause a qualitative
change in some A type K channels, transforming the
fast-inactivating channels into noninactivating, delayed
rectifier-type K channels (Giese et al., 1998). In sum-
mary, although KChIP2s and Kv- subunits can both
serve as regulatory subunits for specific Kv channels,
these accessory proteins may function very differently.
In vitro studies suggest that KChIP2b and KChIP2c
can augment Kv4.2-mediated currents in heterologous
cells by a variety of mechanisms, including increasing
surface channel density, shifting the voltage depen-
dence of activation to more hyperpolarized potentials,
slowing inactivation, and accelerating recovery from in-
Figure 6. Action Potential Prolongation and Rate Dependency in activation (An et al., 2000; Ba¨hring et al., 2001). In mouse
the KChIP2/ Myocytes heart, our data show that KChIP2s do not appear to
(A) Representative action potentials from wild-type (left) and increase surface channel density by enhancing the syn-
KChIP2/ (right) myocytes. Several (5–10) action potentials at stimu-
thesis of Kv4.2 or Kv4.3 since there were no differ-lation rates of 1 Hz and 5 Hz are superimposed. Action potentials
ences at either the RNA or protein level for both Kv4.2at 1 and 5 Hz from the control myocyte are indistinguishable.
and Kv4.3 between the wild-type and the KChIP2/(B) Histograms comparing mean ( SEM) action potential duration
at 50% (t  50%) and 90% (t  90%) of repolarization between the mice (data not shown). Recent studies suggest that
control (n  10) and mutant (n  8) myocytes at stimulation rates KChIP2s may increase the surface expression of Kv4.2
of 1 and 5 Hz. by facilitating the trafficking of the channel (An et al.,
(C) Comparison of the effect of stimulation frequency on 50% and
2000; Ba¨hring et al., 2001). When Kv4.2 is expressed90% repolarization times in control (left) and mutant (right) myo-
alone in heterologous cells, this channel protein iscytes. Plots show the averaged ratio of repolarization time at 5 Hz
mainly retained within the perinuclear endoplasmic re-to 1 Hz for each cell.
ticulum (ER) and Golgi compartments. However, when
Kv4.2 is coexpressed with KChIP2s, both the channeland regulate the functional expression of these channels
and the KChIP2 proteins are translocated and colocal-in vitro. Kv subunits and KChIPs have both been shown
ized on the cell membrane. Based on these observa-to be integral components of specific Kv channel com-
tions, a model can be proposed in which KChIP2s playplexes, whereas KChAP interacts with the Kv channels
a dual role in regulating Ito in cardiac myocytes (Figureonly transiently (Wible et al., 1998). KChIP2, also known
7A). In this working hypothesis, KChIP2s may first inter-as KCNIP2, is the only member of the KChIP gene family
act with the Kv4.2  subunit to facilitate its traffickingthat is preferentially expressed in the heart. The KChIP2
from the ER to the surface membrane. Thereafter,gene can produce three cardiac isoforms, KChIP2a,
KChIP2s may also function to modulate the kineticsKChIP2b, and KChIP2c, by alternative splicing. Both
and gating properties of the channel. In the absence ofKChIP2b and KChIP2c have been previously shown to
KChIP2s, Kv4.2may not be appropriately translocatedinteract specifically with members of the Kv4 subfam-
and modulated, resulting in a loss of Ito.ily, including Kv4.2 and Kv4.3, which underlie Ito in
mouse and human hearts, respectively (An et al., 2000;
A Loss of Ito Increases Dispersion of RepolarizationBa¨hring et al., 2001). Although the pore-forming  sub-
and Confers Marked Susceptibility to Lethalunits of the Kv4 family by themselves can produce Ito-
Forms of Ventricular Tachycardialike currents in heterologous cells, these currents differ
KChIP2/ mice are highly susceptible to the inductionsignificantly from the native currents. Coexpression of
of polymorphic ventricular tachycardia, including ar-Kv4 with KChIP2b or KChIP2c in heterologous expres-
rhythmia closely resembling torsades de pointes, a le-sion systems has been shown to result in reconstitution
thal form of arrhythmia often associated with suddenof several additional features of the native currents.
cardiac death (El-Sherif and Turitto, 2000). Our data sug-However, the in vivo role of KChIP2 in regulating the
expression of Ito in cardiac myocytes remains unclear. gest that this marked genetic susceptibility to arrhyth-
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Figure 7. A Schematic Model of How a Deficiency in KChIP2 May Abolish Ito Expression in Cardiac Myocytes and Confer Susceptibility to
Ventricular Arrhythmias
(A) KChIP2s may play a dual role in regulating Ito in cardiac myocytes. Under normal conditions (left), KChIP2s may first bind to the Kv4.2 
subunit to promote the trafficking of the channel from the endoplasmic reticulum (ER) to the cell membrane. Once cotranslocated to the
surface membrane, KChIP2s may also function to modulate the kinetics and gating properties of the channel. In the absence of KChIP2s
(right), Kv4.2 may not be appropriately translocated and modulated, resulting in a loss of Ito.
(B) A loss of the transmural gradient of Ito expression increases susceptibility to ventricular arrhythmias. The normal gradient of Ito expression
across the ventricular wall (indicated by red dots) is required for the concordant propagation of repolarization (indicated by blue arrows)
across the wall. In the absence of KChIP2s, the transmural gradient of Ito expression is lost, leading to an increased heterogeneity of repolarization
while the propagation of depolarization (indicated by black arrows) remains unaffected. This increased heterogeneity of repolarization can
cause unidirectional block of conduction and can provide a substrate for the reentry circuit (indicated by a red circuit), increasing susceptibility
to arrhythmias. Abbreviations are as follows: AO, aorta; LA, left atrium; and LV, left ventricle.
mias is due to the loss of Ito and the resulting increased the subepicardium and the lowest level in the subendo-
cardium (Na¨bauer et al., 1996). This gradient helps deter-dispersion of repolarization. Ito is largely responsible for
the early repolarization of the cardiac action potential, mine the different APDs in epicardial and endocardial
myocytes and, consequently, the propagation of repo-and it plays an important role in determining the APD.
Consistent with a role of Ito in controlling APD, we have larization across the ventricular wall (Figure 7B). We
have shown that such a transmural gradient of Ito expres-shown that the loss of Ito can lead to prolonged action
potentials in ventricular myocytes. Ito is known to display sion exists in wild-type mice and further demonstrated
a loss of this physiological gradient in the KChIP2/a tightly regulated transmural gradient of expression in
the ventricle across species, with the highest level in mice. Since Ito is expressed differentially across the ven-
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tricular wall, the effect of the loss of Ito on the APD is of Ito seen in heart failure is a critical contributing factor
expected to be nonuniform. A heterogeneous change to the increased risk of lethal arrhythmias associated
in APDs may increase dispersion of repolarization, with this disease.
which can cause unidirectional block of conduction and
contribute to the development of a reentrant circuit (Fig- Maintaining the Ito Gradient via Promoting KChIP2
ure 7B; Baker et al., 2000; Antzelevitch, 2001a). Taken Expression: A Potential New Therapeutic Target
together, our data underline the importance of main- for Suppressing Ventricular Arrhythmias
taining the transmural gradient of Ito expression, and they A transmural gradient of the expression of Ito is a con-
suggest that the loss of this physiological Ito gradient and served feature across species. Our data indicate that a
the resulting increased dispersion of repolarization are loss of this gradient can lead to a marked susceptibility
the underlying causes for the susceptibility to cardiac to ventricular tachycardia. Recent studies in human
arrhythmias in the KChIP2/ mice. hearts have revealed a steep gradient of KChIP2 expres-
Previous studies of a functional knockout of Ito in trans- sion across the ventricular free wall, coinciding with the
genic mice with cardiac-restricted overexpression of transmural gradient of Ito expression. In contrast, Kv4.3
dominant-negative forms of Kv4.2, driven by the myo- expression is constant across the ventricular wall (Ro-
sin heavy chain promoter, also reported marked prolon- sati et al., 2001). These results suggest that KChIP2,
gation of action potentials (Barry et al., 1998; Wickenden rather than Kv4.3, is the primary determinant that un-
et al., 1999). However, these transgenic mice display derlies the transmural gradient of Ito expression in hu-
phenotypes that are very different from that of the man hearts. The regulation of KChIP2 expression is in-
KChIP2/ mice. Overexpression of one form of Kv4.2 volved not only in physiological but also in pathological
dominant-negative mutant resulted in prolonged QT in- changes in Ito expression. A marked reduction in Ito is a
tervals (Barry et al., 1998), whereas overexpression of consistent feature of cardiac hypertrophy and failure in
another form of Kv4.2mutant led to heart failure (Wick- both human and experimental model systems (Beuckel-
enden et al., 1999). In contrast, none of these pheno- mann et al., 1993; Tomita et al., 1994). We have now
types were observed in the KChIP2/ mice. It is known shown that KChIP2 expression is markedly downregu-
that overexpression of a gene in the heart to the level lated in cardiac hypertrophy following pressure overload
of myosin heavy chain can often lead to nonspecific and that the relative level of KChIP2 expression can
effects, which may explain the variable and severe phe- determine the current density of Ito. Thus, the reductionnotypes observed in these transgenic mice. In contrast, of Ito seen in cardiac hypertrophy is, at least in part,our results with the KChIP2-deficient mice define a se- due to a downregulation of KChIP2 expression. In this
lective role of KChIP2 and Ito in the onset of arrhythmias. manner, the downregulation of KChIP2 in the hypertro-
For this reason, the KChIP2/ mice represent the first phied heart recapitulates the fetal heart gene program
genetically based model that demonstrates that a loss (Hunter et al., 1999) as a negatively regulated gene,
of Ito can cause a marked susceptibility to ventricular which may be mediated by distinct signaling pathways.
tachycardia. In addition, these studies identify a class of As KChIP2 can directly control Ito and, consequently,genetic modifiers for malignant ventricular tachycardias
the genetic susceptibility to arrhythmias, it will be inter-
(Chien, 2000), i.e., defects in cytoplasmic modulators of
esting to determine whether mutations in KChIP2 are
channel proteins, suggesting that it may, in the future,
associated with any inherited forms of human arrhyth-
be of interest to directly explore the role of potential
mias. Although the KChIP2/ mice do not display pro-KChIP2 mutations in patients with idiopathic cardiac
longed QT intervals, their ECG waveforms do sharesudden death.
some similarities to those seen in Brugada syndrome,It is clear that a defect in Ito alone is not sufficient to both pointing to an abnormality in early repolarizationinduce arrhythmias, because the KChIP2/ mice do not
(Yan and Antzelevitch, 1999). Mutations in SCN5A, adevelop any spontaneous arrhythmias. This suggests
sodium channel gene, have been identified in a subsetthat a presence of more than one proarrhythmic factor
of patients with Brugada syndrome (Chen et al., 1998).is required for arrhythmogenesis, which is consistent
It has been suggested that mutations in other candidatewith a multihit mechanism previously proposed for a life-
genes that are involved in early repolarization might alsothreatening arrhythmia to occur in human populations
be responsible for this syndrome (Antzelevitch, 2001b).(Keating and Sanguinetti, 2001). In our studies of the
Accordingly, it will be of interest to explore the possibilityKChIP2/ mice, the triggering factor was the extra stim-
that mutations in the KChIP2 gene may ultimately beulus applied during programmed stimulation. In ac-
linked to Brugada syndrome.quired heart diseases that are associated with a sub-
In summary, we have shown that a deficiency instantial reduction in Ito, such as heart failure, the
KChIP2 is sufficient to confer a marked genetic suscepti-triggering factor may be an ectopic beat or premature
bility for lethal forms of ventricular tachycardia throughventricular contraction commonly seen in this clinical
the loss of Ito. Accordingly, KChIP2 may represent a newsetting. Other proarrhythmic factors, such as hypoka-
class of genetic modifiers that can confer risk for bothlemia, ischemia, and antiarrhyhmic agents with Class III
inheritable and acquired forms of ventricular arrhyth-effects, could also be important triggering factors. Our
mias. Since the expression of KChIP2 is downregulatedstudy suggests that a downregulation of Ito in heart fail-
during cardiac remodeling, strategies to maintain Ito byure may directly contribute to the enhanced sensitivity of
promoting the level of KChIP2 expression in the failingthe failing myocardium to many proarrhythmic factors,
heart and/or blocking signaling pathways that triggerwhich can predispose heart failure patients to an in-
its own downregulation during the hypertrophic genecreased risk of sudden cardiac death. Our results pro-
vide new molecular evidence that the downregulation program (Hunter and Chien, 1999) may represent new
Cell
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